Searching. Please wait…
1582
37
171
29406
4423
2606
347
392
Abstract: In 2011, the Spanish Society of Medical Oncology and the Spanish Society of Pathology started a joint project to establish recommendations on biomarker testing in patients with advanced non-small-cell lung cancer based on the current evidence. Most of these recommendations are still valid, but new evidence requires some aspects to be updated. Specifically, the recommendation about which biomarkers to test in which patients is being amended, and the best way to manage tumour samples and minimum requirements for biomarker test material are defined. Suitable techniques for testing for epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement are also reviewed, and a consensus is reached on which situations warrant re-biopsy.
Fuente: Clinical and Translational Oncology, 2015, 17(2), 103-112
Publisher: Springer-Verlag Italia
Year of publication: 2015
No. of pages: 10
Publication type: Article
DOI: 10.1007/s12094-014-1248-9
ISSN: 1699-048X,1699-3055
SCOPUS
Citations
Google Scholar
Metrics
Read publication
FELIP E.
CONCHA Á.
DE CASTRO J.
JOSE JAVIER GOMEZ ROMAN
GARRIDO P.
RAMÍREZ J.
ISLA D.
SANZ J.
PAZ-ARES L.
LÓPEZ-RÍOS F.
Back